RSS

GlobalData

GlobalData, a data and analytics company, has reported that further development of chimeric antigen receptor (CAR)-T cell therapies in solid tumours will require collaboration with industry. more

Analysis

Data and analytics company, GlobalData, has revealed that it believes new launches into the epinephrine injection device market will have the potential to completely transform the space. more

Analysis

After receiving approval for two HIV drugs, Delstrigo and Pifeltro, Merck should be expecting strong sales but probably unlikely to be at blockbuster levels, according to senior pharma analyst at GlobalData. more

Analysis

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

The recent approval of AstraZeneca/Merck’s Lynparza reflects the accelerating pace of Chinese drug approvals under the country’s new policy regime, according to data and analytics company, GlobalData. more

News

Sanofi Genzyme — specialty care global business unit of French pharma company Sanofi — has launched its multiple sclerosis (MS) drug in India, however, according to GlobalData, it should be cautious of fierce generic competition… more

News

Amazon

Eric Broder Van Dyke / Shutterstock.com

According to data and analytics company, GlobalData, Amazon is poised to make huge strides within healthcare as its business model offers easier connectivity between providers and patients and it has a powerful online platform... more

News

According to poll results from Pew Research Center, the American public is accepting of gene editing in animals that could benefit human health, potentially removing a barrier to research, as noted by a pharma analyst at GlobalData. more

Opinion

Based on its latest report, data and analytics company — GlobalData — has revealed that North Americans are the least informed about the General Data Protection Regulation (GDPR). more

News

The recent collaboration between Merck and InnoCore Pharmaceuticals for the development of a new drug delivery platform that will improve compliance could be a step forward in the delivery of biologics, according to GlobalData more

Opinion

Following a dip in the first-quarter operating profit announced by Takeda, which is being attributed to the loss of US exclusivity for its blockbuster cancer drug and a lacking pipeline, it may find a saving grace in its recent merger with Shire more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

According to data and analytics company, GlobalData, personalised medicine is becoming an increasing possibility for patients as a result of newly developed algorithms and the use of big data. more

Analysis

The recently announced ‘Biosimilar Action Plan’ (BAP) from the US Food and Drug Administration (FDA) is another move by the regulatory body to achieve cost-effective pricing, according to an analyst at data and analytics company, GlobalData. more

News

Data and analytics company, GlobalData, has revealed that recent survey findings from the European Medicines Agency (EMA) into Brexit preparedness of the pharma industry support its own conclusions on the matter. more

Analysis

After learning that pharma giant, Merck, has filed for a US patent for a blockchain-based system, GlobalData has been led to believe that the first applications of blockchain will initially be seen in the healthcare supply chain more

Analysis

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

In order to reduce the high level of disabilities and stroke recurrence in cases of acute ischaemic stroke (AIS) it is vital that the diverse unmet needs are addressed, according to data and analytics company, GlobalData. more

Analysis

GlobalData has stated that according to its latest research immune-based gene therapy candidates should prevail in oncology, however, this novel approach is unchartered territory in oncology and will require new regulatory guidelines more

Analysis

An increase in clopidogrel prescriptions could be seen in the US and Europe for secondary ischaemic stroke prevention as a result of the outcomes of the Phase III POINT trial, according to data and analytics company, GlobalData. more

Analysis